ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
Dow Jones
42.801,72
0,52%
Euro vs US Dollar
1,0832
-0,01%
Bitcoin
86.342,18
-0,47%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Catalyst Pharmaceuticals Inc (CPRX) Börsenkurse

Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc (CPRX)

NASDAQ
21,96
0,29
(1,34%)
Geschlossen 08 März 10:00PM
Verzögert um 15 Minuten
22,15
0,19
(0,87%)
Nach Börsenschluss: 12:51AM
Verzögert um 15 Minuten
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
22,15
Gebot
20,00
Fragen
25,00
Volumen
1.021.517
21,40 Tagesbereich 22,24
14,47 52-Wochen-Bereich 24,32
Marktkapitalisierung
2,69B
Handelsende
21,67
Handelsbeginn
21,66
Letzte Trade
10
@
21.85
Letzter Handelszeitpunkt
Finanzvolumen
US$ 22.392.832
VWAP
21,9212
Durchschnittliches Volumen (3 Mio.)
1.176.963
Ausgegebene Aktien
121.449.655
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
37,33
Gewinn pro Aktie (EPS)
0,59
Erlöse
398,2M
Nettogewinn
71,41M

Über Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of p... Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.catalystpharma.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Catalyst Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CPRX. The last closing price for Catalyst Pharmaceuticals was US$21,67. Over the last year, Catalyst Pharmaceuticals shares have traded in a share price range of US$ 14,47 to US$ 24,32.

Catalyst Pharmaceuticals currently has 121.449.655 shares in issue. The market capitalisation of Catalyst Pharmaceuticals is US$2,63 billion. Catalyst Pharmaceuticals has a price to earnings ratio (PE ratio) of 37.33.

CPRX Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
CPRX (1,34%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
CPRX (1,34%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 März 2025
CPRX (1,34%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 März 2025
CPRX (1,34%)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Edgar (US Regulatory)
28 Februar 2025
CPRX (1,34%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
26 Februar 2025
CPRX (1,34%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Februar 2025
CPRX (1,34%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
26 Februar 2025
CPRX (1,34%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.221.0031919744621.9323.388221.45121090622.23893541CS
4-1-4.3196544276523.1523.54520.46108012922.07123074CS
120.713.3115671641821.4424.3219.15117696322.15922205CS
262.6213.415258576519.5324.3219104667421.72674978CS
525.8635.972989564116.2924.3214.47109075918.97615642CS
15614.52190.3014416787.6324.326.15162071814.89589524CS
26018.55515.2777777783.624.322.55156356210.95672558CS

CPRX - Frequently Asked Questions (FAQ)

What is the current Catalyst Pharmaceuticals share price?
The current share price of Catalyst Pharmaceuticals is US$ 22,15
How many Catalyst Pharmaceuticals shares are in issue?
Catalyst Pharmaceuticals has 121.449.655 shares in issue
What is the market cap of Catalyst Pharmaceuticals?
The market capitalisation of Catalyst Pharmaceuticals is USD 2,63B
What is the 1 year trading range for Catalyst Pharmaceuticals share price?
Catalyst Pharmaceuticals has traded in the range of US$ 14,47 to US$ 24,32 during the past year
What is the PE ratio of Catalyst Pharmaceuticals?
The price to earnings ratio of Catalyst Pharmaceuticals is 37,33
What is the cash to sales ratio of Catalyst Pharmaceuticals?
The cash to sales ratio of Catalyst Pharmaceuticals is 6,69
What is the reporting currency for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Catalyst Pharmaceuticals?
The latest annual turnover of Catalyst Pharmaceuticals is USD 398,2M
What is the latest annual profit for Catalyst Pharmaceuticals?
The latest annual profit of Catalyst Pharmaceuticals is USD 71,41M
What is the registered address of Catalyst Pharmaceuticals?
The registered address for Catalyst Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Catalyst Pharmaceuticals website address?
The website address for Catalyst Pharmaceuticals is www.catalystpharma.com
Which industry sector does Catalyst Pharmaceuticals operate in?
Catalyst Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

CPRX Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CPRX
Catalyst Pharmaceuticals
NYSE
PAYC
Paycom Software
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten